Active Purchasing: Empirical Insights From the Dutch Healthcare System and Lessons for Low- and Middle-Income Countries: Comment on "Measuring Active Purchasing in Healthcare: Analysing Reallocations of Funds Between Providers to Evaluate Purchasing Systems Performance in the Netherlands"

TL;DR

This paper analyzes the Dutch healthcare system to show that managed competition alone may not improve efficiency, offering lessons for healthcare reforms in low- and middle-income countries.

Contribution

The paper provides empirical insights into the limitations of managed competition and offers tailored recommendations for healthcare purchasing in low- and middle-income countries.

Findings

The Dutch hospital sector shows limited reallocation of funds between providers.

Managed competition alone may not drive efficiency gains without proper monitoring and incentives.

LMICs should adapt purchasing models and strengthen data use and regulatory frameworks.

Abstract

Stadhouders et al critically examines the assumptions behind managed competition, revealing that competitive systems alone may not drive efficiency gains through fund reallocation. Their findings from the Dutch hospital sector suggest limited or low reallocation of funds between providers and highlight the need for monitoring resource allocation progress, understanding barriers and adjusting incentives for better functioning healthcare markets. For low- and middle-income countries (LMICs) undergoing health reforms, the Dutch experience underscores the importance of tailoring purchasing models to local contexts. LMICs should enhance data use for more strategic decision-making as well as building regulatory framework and institutional capacity for stronger implementation. Future research should explore how purchasing models interact with diverse health system characteristics to inform system-specific reforms.